Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 2004, p. 2292-2294, Vol. 48, No. 6
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.6.2292-2294.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Salmonella Gene rma (ramA) and Multiple-Drug-Resistant Salmonella enterica Serovar Typhimurium
Tahar van der Straaten,1 Riny Janssen,1 Dik J. Mevius,2 and Jaap T. van Dissel1*
Department of Infectious Diseases, Leiden University Medical Center, 2300 RC Leiden,1
Central Institute for Animal Disease Control, CIDC-Lelystad, Lelystad, The Netherlands2
Received 3 November 2003/
Returned for modification 23 December 2003/
Accepted 9 February 2004

ABSTRACT
MarA and its homologue, RamA, have been implicated in multidrug
resistance (MDR).
RamA overexpression in
Salmonella enterica serovar Typhimurium and
Escherichia coli conferred MDR independently
of
marA. Inactivation of
ramA did not affect the antibiotic
susceptibilities of wild-type
S. enterica serovar Typhimurium
or 15 unrelated clinical MDR isolates. Thus,
ramA overexpression
is not a common MDR mechanism in
Salmonella.

TEXT
Multiple antibiotic resistance in
Salmonella enterica serovar
Typhimurium, an etiologic agent of food-borne enterocolitis
in humans, is becoming a serious health problem. A multiple-drug-resistant
(MDR) phenotype can likely develop in gram-negative microorganisms
by many mechanisms (
4); most of these have been elucidated in
Escherichia coli. Among other mechanisms, an important route
involves activation of the
mar locus: MarA, the transcriptional
activator of this locus, mediates drug resistance by causing
decreased expression of the porin OmpF and overexpression of
the multidrug efflux pump ArcB (
1,
9). Additional genetic mechanisms
of MDR have been proposed. For instance, homologues of MarA,
such as Rob and SoxS, have been shown to bind to the
mar box;
and constitutive
soxS or
rob mutants display MDR as well (
3,
8). George and coworkers (
2) identified the
ramA gene in MDR
Klebsiella pneumoniae and suggested that the MDR phenotype of
this strain was caused by constitutive overexpression of RamA.
Because RamA displays close homology to MarA, SoxS, and Rob,
the suggestion was made that RamA mediates MDR in
Klebsiella via activation of the
mar locus. Recently, a gene identical
to
ramA was also identified in
S. enterica serovar Paratyphi
B and was designated
rma (
11). In this report, we describe a
gene identical to
ramA (
rma) in
S. enterica serovar Typhimurium
that, when overexpressed on a plasmid in
E. coli which lacks
ramA, conferred an MDR phenotype to this bacterium and investigate
whether this gene has a role in MDR in
S. enterica serovar Typhimurium.
The strains and plasmids used in this study are listed in Table 1. E. coli marA mutants were kindly provided by S. L. Levy (6). The MDR S. enterica serovar Typhimurium strains were obtained from the surveillance collection of CIDC-Lelystad, Lelystad, The Netherlands, and are representatives of unrelated clinical MDR isolates obtained in The Netherlands over a 2-year period. The ramA gene was inactivated in these strains by transduction with a P22 lysate of the ramA::kanamycin Salmonella mutant (10).
To induce expression of RamA, the RamA-coding sequence was ligated
into the isopropyl-ß-
D-thiogalactopyranoside (IPTG)-inducible
vector pTrcHisA (Invitrogen) by standard techniques. For constitutive
overexpression,
ramA was ligated into pBluescript (Stratagene).
Disk diffusion assays were performed as follows. End-log-phase bacteria (optical density at 600 nm, 0.8) were diluted 1:10 in phosphate-buffered saline and plated on minimal M9 medium. For E. coli the plates were supplemented with thiamine (0.01%) and Casamino Acids (0.1%). If required, ampicillin (50 µg/ml) or IPTG (0.1 mM) was added. Cotton disks containing antibiotics were placed in the centers of the plates. After overnight incubation at 37°C, the bacterium-free zone was determined as a measure of resistance. The disk diffusion assay was used to test the antibiotic susceptibilities of the bacterial mutant strains, for which the classical MIC broth microdilution method is not adequate (5).
The MICs for the clinical Salmonella isolates were determined by the broth microdilution method, according to the NCCLS guidelines (7). An E-test was performed by standard procedures for determination of tetracycline resistance.
Overexpression of RamA confers MDR in S. enterica serovar Typhimurium.
Given the homology between RamA and MarA and the findings for Klebsiella and S. enterica serovar Paratyphi B, we investigated the ability of RamA to confer resistance to various unrelated antibiotics in S. enterica serovar Typhimurium by means of disk diffusion assays. We induced expression of RamA in wild-type Salmonella with the IPTG-inducible ramA plasmid and expressed RamA in E. coli with pBl-ramA. Both microorganisms displayed an MDR phenotype after overexpression of RamA (Table 2), which is in accordance with the published results of George et al. (2) on the expression of RamA in E. coli. Of note, the latter bacterium lacks ramA, and we found that ramA is highly confined to S. enterica serovars (10) and is not present in the genomes of many other members of the family Enterobacteriaceae, with the notable exceptions of K. pneumoniae and Enterobacter cloacae.
The MDR phenotype mediated by RamA is independent of MarA.
Yassien et al. (
11) showed that RamA (Rma) of
S. enterica serovar
Paratyphi B is a DNA binding protein that binds to the
mar box.
MarA is a transcriptional activator for
marRAB and binds to
the
mar box located within
marO. Homologues of MarA, such as
SoxS, Rob, and RamA, have been shown to bind to the
mar box
and also to upregulate expression of the
mar locus (
3,
8,
11).
Thus, on the basis of experiments with
E. coli, Yassien et al.
(
11) hypothesized that RamA can substitute for MarA and directly
activate MarA-controlled genes, leading to an MDR phenotype.
An alternative explanation for their data would be that the
MDR phenotype conferred by overexpression of RamA is MarA dependent.
To investigate this issue we expressed RamA on an IPTG-inducible
multicopy plasmid in a
marA-negative
E. coli mutant and its
parental strain. As assessed by disk diffusion assays, in both
wild-type
E. coli and the
marA-negative mutant, RamA significantly
(
P < 0.025) increased the levels of resistance to multiple
unrelated antibiotics and conferred an MDR phenotype (Table
2). This result demonstrates that in
E. coli RamA can mediate
an MDR phenotype independently of a functionally intact
marA,
likely by direct activation of MarA-controlled genes.
The antibiotic susceptibility of wild-type Salmonella is not affected by inactivation of ramA.
Next, we assayed the resistance of ramA null mutants of S. enterica serovar Typhimurium to multiple unrelated antibiotics. These strains were obtained by gene replacement with suicide vector pGP704, which contains ramA inactivated by a kanamycin cassette (10). Compared with the wild-type parental Salmonella strain, the null mutants did not display increased susceptibilities to tetracycline, chloramphenicol, ciprofloxacin, or nalidixic acid (Table 2). The identical susceptibilities of the Salmonella strains to, for instance, ciprofloxacin were confirmed by E-test on Iso-Sensitest agar plates, with the MICs for all strains being 0.032 to 0.064 mg/liter.
The MDR phenotype of clinical isolates of Salmonella is not affected by inactivation of ramA.
Further evidence that a functionally intact ramA is dispensable for the expression of an MDR phenotype was obtained in experiments with 15 clinical S. enterica serovar Typhimurium isolates (including strain 12 DT104), all of which displayed an MDR phenotype, as defined by resistance to at least three unrelated antibiotics. These strains were obtained from the Dutch national surveillance collection of CIDC-Lelystad and are representative of unrelated clinical MDR isolates obtained in The Netherlands over a 2-year period. In these strains the ramA gene was inactivated by transduction with a P22 lysate of the ramA::kanamycin Salmonella mutant. The MDR phenotype was not reversed to a non-MDR, susceptible phenotype in any of these strains (Table 3), as determined by assays for MICs. In more than 270 assays for MICs, only 2 indicated a change in the MIC of more than 2 dilution steps by the broth microdilution method, according to the NCCLS guidelines (7). The MICs of doxycycline, tetracycline, and florfenicol for six MDR strains showed slight decreases; however, according to the NCCLS guidelines, the interpretation of the final MICs still indicated a resistant phenotype.
In conclusion, overexpression of RamA in
E. coli and
S. enterica serovar Typhimurium confers an MDR phenotype in a MarA-independent
manner that is likely mediated by direct activation of
mar-regulated
genes, although formal proof for this is not yet available.
However, inactivation of
ramA does not lead to enhanced antibiotic
susceptibility and does not reverse the antibiotic resistance
phenotypes of 15 unrelated clinical MDR
S. enterica serovar
Typhimurium isolates. Thus, the findings for
Salmonella rule
against a common role of this gene in the MDR phenotypes of
clinical
Salmonella isolates.

FOOTNOTES
* Corresponding author. Mailing address: Department of Infectious Diseases, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Phone: 31-71-5262613. Fax: 31-71-5266758. E-mail:
j.t.van_dissel{at}lumc.nl.


REFERENCES
1 - Alekshun, M. N., and S. B. Levy. 1997. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob. Agents Chemother. 41:2067-2075.[Medline]
2 - George, A. M., R. M. Hall, and H. W. Stokes. 1995. Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology 141:1909-1920.[Abstract/Free Full Text]
3 - Jair, K. W., X. Yu, K. Skarstad, B. Thony, N. Fujita, A. Ishihama, and R. E. Wolf, Jr. 1996. Transcriptional activation of promoters of the superoxide and multiple antibiotic resistance regulons by Rob, a binding protein of the Escherichia coli origin of chromosomal replication. J. Bacteriol. 178:2507-2513.[Abstract/Free Full Text]
4 - Livermore, D. M. 2003. Bacterial resistance: origins, epidemiology, and impact. Clin. Infect. Dis. 36:S11-S23.[CrossRef][Medline]
5 - Maloy S. R., V. J. Stewart, and R. K. Taylor (ed.). 1996. Genetic analysis of pathogenic bacteria. Cold Spring Harbor course. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
6 - Maneewannakul, K., and S. B. Levy. 1996. Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 40:1695-1698.[Abstract]
7 - National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard. NCCLS document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8 - Oethinger, M., I. Podglajen, W. V. Kern, and S. B. Levy. 1998. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob. Agents Chemother. 42:2089-2094.[Abstract/Free Full Text]
9 - Sulavik, M. C., M. Dazer, and P. F. Miller. 1997. The Salmonella typhimurium mar locus: molecular and genetic analyses and assessment of its role in virulence. J. Bacteriol. 179:1857-1866.[Abstract/Free Full Text]
10 - van der Straaten, T., L. Zulianello, A. van Diepen, D. L. Granger, R. Janssen, and J. T. van Dissel. 2004. Salmonella enterica serovar Typhimurium RamA, intracellular oxidative stress response, and bacterial virulence. Infect. Immun. 72:996-1003.[Abstract/Free Full Text]
11 - Yassien, M. A., H. E. Ewis, C. D. Lu, and A. T. Abdelal. 2002. Molecular cloning and characterization of the Salmonella enterica serovar Paratyphi B rma gene, which confers multiple drug resistance in Escherichia coli. Antimicrob. Agents Chemother. 46:360-366.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, June 2004, p. 2292-2294, Vol. 48, No. 6
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.6.2292-2294.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Ricci, V., Piddock, L. J. V.
(2009). Ciprofloxacin selects for multidrug resistance in Salmonella enterica serovar Typhimurium mediated by at least two different pathways. J Antimicrob Chemother
63: 909-916
[Abstract]
[Full Text]
-
Zheng, J., Cui, S., Meng, J.
(2009). Effect of transcriptional activators RamA and SoxS on expression of multidrug efflux pumps AcrAB and AcrEF in fluoroquinolone-resistant Salmonella Typhimurium. J Antimicrob Chemother
63: 95-102
[Abstract]
[Full Text]
-
Bailey, A. M., Paulsen, I. T., Piddock, L. J. V.
(2008). RamA Confers Multidrug Resistance in Salmonella enterica via Increased Expression of acrB, Which Is Inhibited by Chlorpromazine. Antimicrob. Agents Chemother.
52: 3604-3611
[Abstract]
[Full Text]
-
Nikaido, E., Yamaguchi, A., Nishino, K.
(2008). AcrAB Multidrug Efflux Pump Regulation in Salmonella enterica serovar Typhimurium by RamA in Response to Environmental Signals. J. Biol. Chem.
283: 24245-24253
[Abstract]
[Full Text]
-
Webber, M. A., Randall, L. P., Cooles, S., Woodward, M. J., Piddock, L. J. V.
(2008). Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother
62: 83-91
[Abstract]
[Full Text]
-
Abouzeed, Y. M., Baucheron, S., Cloeckaert, A.
(2008). ramR Mutations Involved in Efflux-Mediated Multidrug Resistance in Salmonella enterica Serovar Typhimurium. Antimicrob. Agents Chemother.
52: 2428-2434
[Abstract]
[Full Text]
-
Chen, S., Cui, S., McDermott, P. F., Zhao, S., White, D. G., Paulsen, I., Meng, J.
(2007). Contribution of Target Gene Mutations and Efflux to Decreased Susceptibility of Salmonella enterica Serovar Typhimurium to Fluoroquinolones and Other Antimicrobials. Antimicrob. Agents Chemother.
51: 535-542
[Abstract]
[Full Text]
-
Piddock, L. J. V.
(2006). Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria. Clin. Microbiol. Rev.
19: 382-402
[Abstract]
[Full Text]
-
Webber, M., Buckley, A. M., Randall, L. P., Woodward, M. J., Piddock, L. J. V.
(2006). Overexpression of marA, soxS and acrB in veterinary isolates of Salmonella enterica rarely correlates with cyclohexane tolerance. J Antimicrob Chemother
57: 673-679
[Abstract]
[Full Text]